We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:KNSA
​
​
logo

Kiniksa Pharmaceuticals International, (KNSA)

Nasdaq • KNSA • GB00BRXB0C07

Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 2, 2026, ORTEX estimates 10.2% of free float is sold short, 4.4 days to cover, cost to borrow 0.48%.

Market Cap

7.33b USD | # 1988 in US

Volume

634.58k shares | 50.31m USD

Shares Outstanding

48.29m

Free Float Shares

78.53% | 37.92m

News

KNSA key data

Kiniksa Pharmaceuticals International, (Nasdaq: KNSA) has a market capitalization of $7.33B. Last close $93.30 (as of 2026-11-04); 52-week range $37.02 to $98.48. ORTEX data as of 2026-11-02: short interest is 10.18% of free float, 4.4 days to cover and the average cost to borrow is 0.48%.

  • KNSA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.